OMRON Healthcare Thailand Launches Next-Gen Smart Blood Pressure Monitors: EZ Series, IQ Series, and HEM-7383T1 with Advanced AFib Detection

OMRON Healthcare Thailand Launches Next-Gen

Smart Blood Pressure Monitors: EZ Series,

IQ Series, and HEM-7383T1 with Advanced AFib Detection

Debuts the Emotional Brand Film “A Caring Hug” to Raise Public Awareness for Early Stroke Prevention and Cardiovascular Home Care.

BANGKOK, THAILAND – June 30, 2026 – OMRON Healthcare (Thailand) Co., Ltd., a subsidiary of OMRON Healthcare and a global leader in clinically proven home medical equipment for health monitoring and treatment, is revolutionizing personal heart health management. The company has announced the launch of its latest smart blood pressure monitor line-up: the EZ Series, IQ Series, and HEM-7383T1.

Equipped with next-generation technology, these breakthrough devices allow users to screen for potential Atrial Fibrillation (AFib)—a major trigger for stroke—during routine blood pressure checks with just a single touch. This innovative line-up aims to sustainably reduce mortality and disability rates from stroke among the Thai population. It addresses a critical national health crisis, with statistics revealing that 1 in 4 Thai adults is at risk of hypertension, and nearly 50% are unaware of their condition due to its asymptomatic nature.

Driving Proactive Screening with 'Going for ZERO' Strategy and AI Integration

Mr. Yusuke Kato, Managing Director of OMRON Healthcare (Thailand) Co., Ltd., stated that under the corporate vision of “Going for ZERO”—which aims to eliminate severe cardiovascular events in the country—the company has developed these new monitors to shift public behavior from reactive management to proactive "Home Blood Pressure Monitoring".

"Allowing a disease to progress until symptoms appear can be too late. OMRON has developed this technology so that home blood pressure monitoring is not just about numbers, but serves as a 'key to saving lives'. By integrating blood pressure tracking and AFib detection into a single, one-touch device, we empower users to notice early warning signs before they develop into a stroke."

The new series features OMRON’s proprietary Intellisense AFib technology, which utilizes an advanced AI-driven algorithm to analyze Pressure Pulse Waves (PPW) generated by heart contractions. This technology detects specific irregularities in heartbeat patterns associated with AFib. This breakthrough simplifies critical stroke risk screening, making it possible to screen for AFib via a single blood pressure measurement without requiring separate, complex electrocardiogram (ECG) recordings at a hospital.

Addressing Thailand's Silent Health Crisis

Hypertension remains an escalating public health challenge in Thailand, heavily contributing to the national burden of stroke, heart disease, kidney failure, and dementia. According to data from the World Health Organization (WHO) Thailand:

• One in four Thai adults lives with hypertension. Worryingly, only about 30% have their condition under control, while nearly half remain entirely unaware of their hypertensive status.
• Nearly 50% are unaware of their illness because the disease typically presents no symptoms, earning it the nickname the "Silent Killer".
• Stroke stands as a leading cause of mortality nationwide. Notably, 58% of all stroke cases are directly attributable to uncontrolled blood pressure.

This risk compounds severely when combined with Atrial Fibrillation (AFib), a common cardiac arrhythmia that multiplies stroke risk by five times. Thai clinical evidence confirms that AFib prevalence rises sharply with age, reinforcing the critical need for simultaneous blood pressure monitoring and early arrhythmia screening.

Three Choices Tailored for Diverse Family Needs

To cater to different user profiles and family needs, the new portfolio offers three distinct choices:

• EZ Series (Practicality for First-Time Users): Designed for effortless operation, the EZ Series provides reliable accuracy for health-conscious beginners. Select models feature an expanded, ergonomic cuff range (22–42 cm) to comfortably accommodate larger upper arms. Additionally, the series introduces eco-saving technology that improves energy efficiency by up to 1.5 times compared to legacy models.
• IQ Series (Build for Senior Citizen for Enhanced Peace of Mind): Engineered for advanced monitoring, the IQ Series features Intellisense AFib technology and a larger, high-visibility display optimized for older adults. It is equipped with OMRON’s renowned IntelliWrap™Cuff technology, providing measurement accuracy around the upper arm to mitigate errors caused by incorrect cuff placement.
• HEM-7383T1 (Next-Level Connected Stroke Risk Management): The flagship HEM-7383T1 seamlessly bridges clinical precision with smart connectivity. Featuring Intellisense AFib and the IntelliWrap™ Cuff, this Bluetooth-enabled device syncs measurements effortlessly. It empowers users to track long-term health trends and proactively share insights with medical professionals to systematically manage severe cardiovascular risks ahead of time.

Reflecting OMRON’s commitment to premium quality, all models come with a standard 3-year warranty, with an additional 2 to 3 years of extended coverage available upon online registration.

Clinical and Emotional Support for Thai Families

Commenting on the clinical significance of early AFib detection, Asst. Prof. Surat Tanprawate, MD, Neurologist, Faculty of Medicine, Chiang Mai University, said: "Stroke remains one of the leading causes of disability and death, yet many of its major risk factors can be identified before a stroke occurs. High blood pressure and atrial fibrillation (AFib) are two of the most important modifiable risk factors, and they often coexist. One of the greatest clinical challenges is that AFib is frequently asymptomatic or intermittent, meaning many individuals remain unaware they have the condition until they experience a stroke. Importantly, AFib-related strokes are often more severe and are associated with higher mortality and greater long-term disability.

Having the ability to screen for possible AFib during a routine blood pressure measurement represents an important step toward earlier detection and timely medical evaluation. While this technology does not replace a physician's diagnosis, it can help identify individuals who may benefit from further medical evaluation and appropriate treatment. Earlier detection creates opportunities for earlier intervention, helping reduce the burden of stroke and improve long-term cardiovascular health.

To drive public awareness of preventative care and build an emotional connection, Ms. Patama Boonratana, Marketing Manager of OMRON Healthcare (Thailand) Co., Ltd., added that the company has debuted a new brand film titled “A Caring Hug”

The film bridges the gap between clinical excellence and family wellness by reframing routine health checks as acts of love. It uses a warm, familial hug as a direct metaphor for the comfort and precision of OMRON’s IntelliWrap™ Cuff technology, illustrating how smart home monitoring brings collective peace of mind to both caregivers and their loved ones. The brand film is now available on the official OMRON Healthcare Asia Pacific YouTube channel.

For more information about OMRON Healthcare Thailand, please visit our official channels:

Website: https://www.omronhealthcare-ap.com/th

Facebook: https://www.facebook.com/OMRONHealthcareThailand

TikTok: https://www.tiktok.com/@omronhealthcare.th

LINE Official Account: @Omronhealthcare

YouTube: OMRON Healthcare Asia Pacific


About OMRON Healthcare

OMRON Healthcare Co., Ltd. is a global leader and developer in clinically proven medical equipment for home health monitoring and treatment. Committed to minimizing the global impact of chronic conditions, OMRON develops comprehensive, end-to-end solutions for cardiovascular management, remote patient monitoring, respiratory care, and pain therapy.

With over 50 years of leadership in the medical device category, OMRON empowers individuals to proactively manage their health at home through cutting-edge, user-centric technologies. The company’s comprehensive flagship portfolio includes blood pressure monitors, nebulizers, digital thermometers, body composition monitors, and electronic nerve stimulators (TENS).

Driven by its corporate vision, “Going for ZERO, Preventive Care for the Health of Society,” OMRON strives to eliminate severe health events caused by the "silent killer". With global sales exceeding 350 million units, OMRON stands as the world’s most recommended blood pressure monitor brand by healthcare professionals, trusted by users in over 130 countries. Through continuous innovation, OMRON Healthcare remains dedicated to enhancing the quality of life and contributing to a healthier, better society by inspiring people to take charge of their personal well-being.

Source:

WHO Thailand: Reducing cardiovascular disease (hypertension and sodium)

https://www.who.int/thailand/activities/reducing-cardiovascular-diseasewho

WHO Thailand: On World Hypertension Day, Tackling a “Silent Killer”

https://www.who.int/thailand/news/feature-stories/detail/on-world-hypertension-day--tackling-a--silent-killerwho

WHO Thailand: Launch of the WHO Global Hypertension Report 2025

https://www.who.int/thailand/news/detail/24-09-2025-launch-of-the-who-global-hypertension-report-2025who

WHO Global Hypertension Report 2025

https://www.who.int/publications/i/item/9789240115569